Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

Y0001084

Acetazolamid für die Systemeignung

European Pharmacopoeia (EP) Reference Standard

Synonym(e):

Acetazolamid, 5-Acetamido-1,3,4-thiadiazol-2-sulfonamid, N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)-acetamid, N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl)-acetamid

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C4H6N4O3S2
CAS-Nummer:
59-66-5
Molekulargewicht:
222.25
MDL-Nummer:
MFCD00003105
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329831254
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

acetazolamide

Hersteller/Markenname

EDQM

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

Lagertemp.

2-8°C

SMILES String

CC(=O)Nc1nnc(s1)S(N)(=O)=O

InChI

1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)

InChIKey

BZKPWHYZMXOIDC-UHFFFAOYSA-N

Angaben zum Gen

human ... CA1(759) , CA12(771) , CA2(760) , CA4(762)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Carboanhydrasehemmer; erhöht den zerebralen Blutfluss.

Biochem./physiol. Wirkung

Hemmt die Wasserdurchlässigkeit von Membranen durch Interaktion mit Aquaporinen

Verpackung

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

1005004

Acetazolamid, United States Pharmacopeia (USP) Reference Standard

A0100000

Acetazolamid, European Pharmacopoeia (EP) Reference Standard

1005059

Acetazolamid-verwandte Verbindung E, United States Pharmacopeia (USP) Reference Standard

1005048

Acetazolamid-verwandte Verbindung D, United States Pharmacopeia (USP) Reference Standard

PHR1908

Acetazolamid, Pharmaceutical Secondary Standard; Certified Reference Material

BP904

Acetazolamid, British Pharmacopoeia (BP) Reference Standard

PHR2826

Acetazolamid-verwandte Verbindung D, certified reference material, pharmaceutical secondary standard

Piktogramme

Exclamation mark
GHS07

Signalwort

Warning

H-Sätze

H315,H319

Gefahreneinstufungen

Eye Irrit. 2 - Skin Irrit. 2

WGK

WGK 2

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Choose from one of the most recent versions:

Analysenzertifikate (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Gladys E Granero et al.
Expert opinion on drug delivery, 7(8), 943-953 (2010-06-23)
Acetazolamide (ACZ), a carbonic anhydrase inhibitor (CAI), and other oral CAIs have been an integral part of antiglaucoma therapy for > 40 years. ACZ is used orally for the reduction of intraocular pressure in patients suffering from glaucoma. However, this
David E Leaf et al.
Journal of applied physiology (Bethesda, Md. : 1985), 102(4), 1313-1322 (2006-10-07)
Acetazolamide, a potent carbonic anhydrase (CA) inhibitor, is the most commonly used and best-studied agent for the amelioration of acute mountain sickness (AMS). The actual mechanisms by which acetazolamide reduces symptoms of AMS, however, remain unclear. Traditionally, acetazolamide's efficacy has
Indu Pal Kaur et al.
International journal of pharmaceutics, 248(1-2), 1-14 (2002-11-14)
Through this review it is contemplated that acetazolamide (ACZ), an age-old treatment for glaucoma with a myriad of side effects and inadequate topical effectiveness, may be formulated into a topically effective agent by utilizing various newer formulation approaches of ocular
G Settakis et al.
European journal of neurology, 10(6), 609-620 (2003-12-04)
Pathologic processes affecting the brain vessels may damage cerebral vasodilatory capacity. Early detection of cerebral dysfunction plays an important role in the prevention of cerebrovascular diseases. In recent decades acetazolamide (AZ) has frequently been used for this purpose. In the
Neil D Ritchie et al.
Journal of travel medicine, 19(5), 298-307 (2012-09-05)
Acetazolamide has been reported to be effective in the prevention of acute mountain sickness (AMS). Our aim was to conduct a systematic review of randomized, placebo-controlled trials of acetazolamide in the prevention of AMS. Studies were identified by searching the
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.